The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 29, 2026 | Mor George Adi | Chief Executive Officer, Director | Sell(P) | 5K | $2.05 | $10K |
| May 29, 2026 | Mor George Adi | Chief Executive Officer, Director | Sell(P) | 5K | $2.08 | $10K |
| May 29, 2026 | Mor George Adi | Chief Executive Officer, Director | Other(J) | 32K | — | — |
| May 29, 2026 | Mor George Adi | Chief Executive Officer, Director | Other(J) | 19K | — | — |
| Jun 16, 2023 | Quigley Jill M. | Director | Grant(A) | 7K | — | $0 |
| Jun 14, 2023 | Darvish Nissim | Director | Grant(A) | 21K | — | $0 |
| Jun 14, 2023 | Fatal Sigal | Chief Financial Officer | Grant(A) | 103K | — | $0 |
| Mar 16, 2023 | Darvish Nissim | Director | Grant(A) | 7K | — | $0 |
| Mar 16, 2023 | Darvish Nissim | Director | Grant(A) | 7K | — | $0 |
| Mar 16, 2023 | Cohen Neil Harris | Director | Grant(A) | 7K | — | $0 |
| Mar 16, 2023 | Nicaise Claude | Director | Grant(A) | 12K | — | $0 |
| Mar 16, 2023 | Nicaise Claude | Director | Grant(A) | 7K | — | $0 |
| Mar 16, 2023 | Nicaise Claude | Director | Grant(A) | 7K | — | $0 |
| Mar 16, 2023 | Moses Alan Charles | Director | Grant(A) | 7K | — | $0 |
| Jan 3, 2023 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Sell(S) | 71K | $4.51 | $318K |
| Jan 3, 2023 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Sell(S) | 266K | $3.34 | $890K |
| Jan 3, 2023 | Mor George Adi | Chief Scientific Officer, Director | Sell(S) | 6K | $5.03 | $31K |
| Jan 3, 2023 | Mor George Adi | Chief Scientific Officer, Director | Sell(S) | 8K | $5.03 | $39K |
| Nov 16, 2022 | Mor George Adi | Chief Scientific Officer, Director | Sell(S) | 325K | $2.08 | $676K |
| Nov 16, 2022 | Mor George Adi | Chief Scientific Officer, Director | Sell(S) | 257K | $2.08 | $535K |
| Nov 16, 2022 | Cohen Neil Harris | Director | Sell(S) | 2K | $2.00 | $5K |
| Nov 8, 2022 | Fatal Sigal | Chief Financial Officer | Grant(A) | 29K | — | $0 |
| Jun 16, 2022 | Quigley Jill M. | Director | Grant(A) | 14K | — | $0 |
| May 24, 2022 | Maryles Joel Michael | Director | Buy(P) | 400 | $2.89 | $1K |
| May 24, 2022 | Maryles Joel Michael | Director | Buy(P) | 33 | $2.76 | $91 |
| May 18, 2022 | Cohen Neil Harris | Director | Buy(P) | 2K | $3.19 | $6K |
| Mar 18, 2022 | Maryles Joel Michael | Director | Buy(P) | 500 | $4.36 | $2K |
| Mar 18, 2022 | Maryles Joel Michael | Director | Buy(P) | 500 | $4.32 | $2K |
| Mar 16, 2022 | Marvin Donald | Executive VP, CFO & COO | Buy(P) | 250 | $3.30 | $825 |
| Mar 16, 2022 | Marvin Donald | Executive VP, CFO & COO | Buy(P) | 250 | $3.25 | $813 |
| Mar 14, 2022 | Cohen Neil Harris | Director | Buy(P) | 2K | $4.56 | $9K |
| Mar 14, 2022 | Cohen Neil Harris | Director | Buy(P) | 2K | $4.30 | $9K |
| Mar 14, 2022 | Cohen Neil Harris | Director | Buy(P) | 2K | $4.20 | $8K |
| Mar 14, 2022 | Pfost Dale R | Chief Executive Officer, Director | Buy(P) | 700 | $3.97 | $3K |
| Mar 14, 2022 | Pfost Dale R | Chief Executive Officer, Director | Buy(P) | 2K | $3.98 | $7K |
| Mar 14, 2022 | Marvin Donald | Executive VP, CFO & COO | Buy(P) | 250 | $3.90 | $975 |
| Mar 14, 2022 | Marvin Donald | Executive VP, CFO & COO | Buy(P) | 250 | $4.10 | $1K |
| Mar 14, 2022 | Marvin Donald | Executive VP, CFO & COO | Buy(P) | 250 | $4.20 | $1K |
| Mar 14, 2022 | Marvin Donald | Executive VP, CFO & COO | Buy(P) | 250 | $4.00 | $1K |
| Mar 14, 2022 | Marvin Donald | Executive VP, CFO & COO | Buy(P) | 250 | $3.98 | $995 |
| Mar 11, 2022 | Darvish Nissim | Director | Buy(P) | 1K | $4.28 | $5K |
| Mar 7, 2022 | Darvish Nissim | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Darvish Nissim | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Cohen Neil Harris | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Moses Alan Charles | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Cohen Neil Harris | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Cohen Neil Harris | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Maryles Joel Michael | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Maryles Joel Michael | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Moses Alan Charles | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Cohen Neil Harris | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Nicaise Claude | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Darvish Nissim | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Darvish Nissim | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Cohen Neil Harris | Director | Grant(A) | 7K | — | $0 |
| Mar 7, 2022 | Maryles Joel Michael | Director | Grant(A) | 7K | — | $0 |
| Dec 6, 2021 | Cohen Neil Harris | Director | Buy(P) | 2K | $7.43 | $15K |
| Nov 11, 2021 | Fatal Sigal | Chief Financial Officer | Grant(A) | 36K | — | $0 |
| Nov 8, 2021 | Marvin Donald | Executive VP, CFO & COO | Grant(A) | 197K | — | $0 |
| Nov 8, 2021 | Marvin Donald | Executive VP, CFO & COO | Grant(A) | 197K | — | $0 |
| Oct 25, 2021 | Pfost Dale R | Chief Executive Officer, Director | Grant(A) | 459K | — | $0 |
| May 7, 2021 | Fatal Sigal | Chief Financial Officer | Grant(A) | 36K | — | $0 |
| Apr 19, 2021 | Squinto Stephen P | Director | Grant(A) | 24K | — | $0 |
| Apr 19, 2021 | Nicaise Claude | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Moses Alan Charles | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Maryles Joel Michael | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Darvish Nissim | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Cohen Neil Harris | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Darvish Nissim | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Darvish Nissim | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Cohen Neil Harris | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Moses Alan Charles | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Cohen Neil Harris | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Cohen Neil Harris | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Maryles Joel Michael | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Maryles Joel Michael | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Moses Alan Charles | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Nicaise Claude | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Darvish Nissim | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Darvish Nissim | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Cohen Neil Harris | Director | Grant(A) | 12K | — | $0 |
| Apr 19, 2021 | Maryles Joel Michael | Director | Grant(A) | 12K | — | $0 |
| Mar 16, 2021 | Cohen Neil Harris | Director | Grant(A) | 688 | — | $0 |
| Mar 16, 2021 | Cohen Neil Harris | Director | Grant(A) | 688 | — | $0 |
| Mar 16, 2021 | Cohen Neil Harris | Director | Grant(A) | 688 | — | $0 |
| Mar 16, 2021 | Darvish Nissim | Director | Grant(A) | 10K | — | $0 |
| Mar 16, 2021 | Cohen Neil Harris | Director | Grant(A) | 688 | — | $0 |
| Mar 15, 2018 | Mor George Adi | Chief Scientific Officer, Director | Grant(A) | 132K | — | $0 |
| Mar 15, 2018 | Mor George Adi | Chief Scientific Officer, Director | Grant(A) | 132K | — | $0 |
| Oct 28, 2016 | Darvish Nissim | Director | Grant(A) | 10K | — | $0 |
| Oct 28, 2016 | Mor George Adi | Chief Scientific Officer, Director | Grant(A) | 34K | — | $0 |
| Oct 28, 2016 | Darvish Nissim | Director | Grant(A) | 10K | — | $0 |
| Oct 28, 2016 | Mor George Adi | Chief Scientific Officer, Director | Grant(A) | 34K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).